INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82 | +20.6% | 3,263 | 0.0% | 0.00% | – |
| Q2 2023 | $68 | -84.6% | 3,263 | -87.4% | 0.00% | -100.0% |
| Q1 2023 | $442 | +927.9% | 25,958 | +1102.9% | 0.00% | – |
| Q4 2022 | $43 | -100.0% | 2,158 | -80.1% | 0.00% | – |
| Q3 2022 | $233,000 | -8.6% | 10,848 | -16.3% | 0.00% | – |
| Q2 2022 | $255,000 | -52.3% | 12,968 | -43.1% | 0.00% | -100.0% |
| Q1 2022 | $535,000 | -34.9% | 22,785 | -24.5% | 0.00% | 0.0% |
| Q4 2021 | $822,000 | -39.5% | 30,189 | -38.8% | 0.00% | -50.0% |
| Q3 2021 | $1,358,000 | +1686.8% | 49,345 | +2036.1% | 0.00% | – |
| Q4 2020 | $76,000 | +10.1% | 2,310 | +6.4% | 0.00% | – |
| Q3 2020 | $69,000 | +40.8% | 2,171 | -30.4% | 0.00% | – |
| Q1 2020 | $49,000 | +1125.0% | 3,119 | +1034.2% | 0.00% | – |
| Q3 2013 | $4,000 | – | 275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |